During the past decade, North Coast Cancer Care conducted 77 clinical trials. In the 10-year time frame, 77 clinical trials started and 133 clinical trials were completed, i.e. on average, 172.7% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 48 clinical trials were completed. i.e. 171.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North Coast Cancer Care" #1 sponsor was "National Cancer Institute (NCI)" with 75 trials, followed by "Alliance for Clinical Trials in Oncology" with 63 trials sponsored, "SWOG Cancer Research Network" with 39 trials sponsored, "NRG Oncology" with 14 trials sponsored and "Radiation Therapy Oncology Group" with 14 trials sponsored. Other sponsors include 31 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Coast Cancer Care" #1 collaborator was "National Cancer Institute (NCI)" with 156 trials as a collaborator, "NRG Oncology" with 27 trials as a collaborator, "NCIC Clinical Trials Group" with 17 trials as a collaborator, "Cancer and Leukemia Group B" with 14 trials as a collaborator and "SWOG Cancer Research Network" with 10 trials as a collaborator. Other collaborators include 43 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "North Coast Cancer Care" are "Breast Cancer" (34 trials), "Lung Cancer" (16 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (13 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials) and "Recurrent Breast Carcinoma" (9 trials). Many other conditions were trialed in "North Coast Cancer Care" in a lesser frequency.

Most popular intervention types in "North Coast Cancer Care" are "Drug" (199 trials), "Other" (121 trials), "Biological" (95 trials), "Radiation" (52 trials) and "Procedure" (30 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (56 trials), "Quality-of-Life Assessment" (35 trials), "placebo" (26 trials), "Paclitaxel" (24 trials) and "Cisplatin" (21 trials). Other intervention names were less common.

The vast majority of trials in "North Coast Cancer Care" are 192 trials for "All" genders, 32 trials for "Female" genders and 16 trials for "Male" genders.

Currently, there are NaN active trials in "North Coast Cancer Care". undefined are not yet recruiting, 31 are recruiting, 67 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 118 completed trials in North Coast Cancer Care, 5 suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in North Coast Cancer Care, 6 "Phase 1" clinical trials were conducted, 98 "Phase 2" clinical trials and 142 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".